[Comment] Treatment of preschool children for schistosomiasis

The following two tabs change content below.
Lancet Global Health
The Lancet Global Health is The Lancet's first gold open-access title and focuses on original research, commentary, correspondence and blogs on topics including maternal and child health, infectious and noncommunicable diseases, mental health, and more. The Editor is Zoë Mullan.

In The Lancet Global Health, Jean T Coulibaly and colleagues1 report the efficacy and safety of different dosages of praziquantel in preschool children. In a randomised dose-ranging trial in southern Côte d’Ivoire, they compared the cure rate obtained with three different doses of praziquantel or placebo, in preschool and school-aged children infected with Schistosoma mansoni. 161 (24%) of 660 eligible preschool-aged children had a detectable S mansoni infection and 154 received treatment. 62% of preschool-aged children were cured with the 20 mg/kg dose, 72% with the 40 mg/kg dose, 71% with the 60 mg/kg dose, and 37% with placebo.

Continue reading: 

[Comment] Treatment of preschool children for schistosomiasis